Key Metrics
0.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q2
Oncology
SJR
- Q2 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Chloride channel
- Superficial radiotherapy
- Bevacizumab
- Lenalidomide
- Skin cancer
- Tyrosine kinase
- Objective response
- Refractory Multiple Myeloma
- Overall survival
- Diarrhea
- Complete resection
- Advanced disease
- Penile cancer
- Liquid biopsy
- Quality of life
- Maintenance therapy
- Epidermal growth factor receptor
- Reference product
- Pandemic
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 4500 | USD 5600 | GBP 4100 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Article Processing Charges | EUR 4500 | USD 5600 | GBP 4100 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Oncology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines
- 12 May 22
- Oncology and Therapy
-
Full paper
Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men
- 7 Feb 22
- Oncology and Therapy
-
Full paper
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
- 15 Jan 22
- Oncology and Therapy
-
Full paper
Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature
- 20 Nov 21
- Oncology and Therapy
-
Full paper
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
- 15 Nov 21
- Oncology and Therapy
-
Full paper
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status
- 25 Jul 21
- Oncology and Therapy
Scite analysis
Powered by scite_
238 articles received 1.5k citations see all
- 52 Supporting
- 1,432 Mentioning
- 12 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 4 Corrections
- 3 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
82%
4 to 6 months
16%
7 to 9 months
0%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Oncology and Therapy been actively publishing?
Oncology and Therapy has been in operation since 2016 till date.
What is the publishing frequency of Oncology and Therapy ?
Oncology and Therapy published with a Semi-annual frequency.
How many articles did Oncology and Therapy publish last years ?
In 2023, Oncology and Therapy published articles.
What is the eISSN & pISSN for Oncology and Therapy ?
For Oncology and Therapy,eISSN is 2366-1089 and pISSN is2366-1070.
What is Citescore for Oncology and Therapy ?
Citescore for Oncology and Therapy is 0.3.
What is H index for Oncology and Therapy ?
H index for Oncology and Therapy is 5.
What is the SJR for Oncology and Therapy ?
SJR for Oncology and Therapy is Q2.
Who is the publisher of Oncology and Therapy ?
SPRINGER is the publisher of Oncology and Therapy.